Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Expression and Function of Transient Receptor Potential Ankyrin 1 Ion Channels in the Caudal Nucleus of the Solitary Tract.

Feng L, Uteshev VV, Premkumar LS.

Int J Mol Sci. 2019 Apr 26;20(9). pii: E2065. doi: 10.3390/ijms20092065.

2.

Treatment duration affects cytoprotective efficacy of positive allosteric modulation of α7 nAChRs after focal ischemia in rats.

Gaidhani N, Uteshev VV.

Pharmacol Res. 2018 Oct;136:121-132. doi: 10.1016/j.phrs.2018.09.001. Epub 2018 Sep 8.

PMID:
30205140
3.

Duration of isoflurane-based surgical anesthesia determines severity of brain injury and neurological deficits after a transient focal ischemia in young adult rats.

Gaidhani N, Sun F, Schreihofer D, Uteshev VV.

Brain Res Bull. 2017 Sep;134:168-176. doi: 10.1016/j.brainresbull.2017.07.018. Epub 2017 Jul 27.

PMID:
28755978
4.

Stroke Cytoprotection: Can Repeating History with New Expectations Really Be the Path to Success in Stroke Research?

Lapchak PA, Uteshev VV.

Transl Stroke Res. 2017 Apr;8(2):104-106. doi: 10.1007/s12975-017-0528-4. Epub 2017 Mar 1. No abstract available.

PMID:
28251583
5.

Cerebrospinal Fluid Levels of Monoamine Metabolites in the Epileptic Baboon.

Szabó CÁ, Patel M, Uteshev VV.

J Primatol. 2015 Dec;4(2). pii: 129. Epub 2015 Oct 14.

6.

Boosting Endogenous Resistance of Brain to Ischemia.

Sun F, Johnson SR, Jin K, Uteshev VV.

Mol Neurobiol. 2017 Apr;54(3):2045-2059. doi: 10.1007/s12035-016-9796-3. Epub 2016 Feb 24.

7.

Editorial: Effective and Promising Treatments for Neurological Disorders and Cancer.

Uteshev VV.

Curr Pharm Des. 2016;22(14):1979-80. No abstract available.

PMID:
26899733
8.
9.

The Cholinergic Potential, the Vagus Nerve and Challenges in Treatment of Traumatic Brain Injury.

Uteshev VV, Tenovuo O, Gaidhani N.

Curr Pharm Des. 2016;22(14):2083-92. Review.

PMID:
26818869
10.

Targeting the Cholinergic System for Neuroprotection and/or Enhancement of Functional Recovery Following Neurotrauma.

Huber KB, Uteshev VV, Pauly JR.

Curr Pharm Des. 2016;22(14):2072-82. Review.

PMID:
26818862
11.

High therapeutic potential of positive allosteric modulation of α7 nAChRs in a rat model of traumatic brain injury: proof-of-concept.

Gatson JW, Simpkins JW, Uteshev VV.

Brain Res Bull. 2015 Mar;112:35-41. doi: 10.1016/j.brainresbull.2015.01.008. Epub 2015 Jan 31.

12.

Nicotine enhances inhibition of mouse vagal motor neurons by modulating excitability of premotor GABAergic neurons in the nucleus tractus solitarii.

Xu H, Boychuk JA, Boychuk CR, Uteshev VV, Smith BN.

J Neurophysiol. 2015 Feb 15;113(4):1165-74. doi: 10.1152/jn.00614.2014. Epub 2014 Nov 26.

13.

Projection target-specific action of nicotine in the caudal nucleus of the solitary tract.

Feng L, Uteshev VV.

J Neurosci Res. 2014 Nov;92(11):1560-72. doi: 10.1002/jnr.23436. Epub 2014 Jun 27.

PMID:
24975270
14.

The therapeutic promise of positive allosteric modulation of nicotinic receptors.

Uteshev VV.

Eur J Pharmacol. 2014 Mar 15;727:181-5. doi: 10.1016/j.ejphar.2014.01.072. Epub 2014 Feb 12. Review.

15.

Evidence for the exclusive expression of functional homomeric α7 nAChRs in hypothalamic histaminergic tuberomammillary neurons in rats.

Tischkau S, Mhaskar Y, Uteshev VV.

Neurosci Lett. 2014 Mar 20;563:107-11. doi: 10.1016/j.neulet.2014.01.047. Epub 2014 Jan 31.

16.

The dual effect of PNU-120596 on α7 nicotinic acetylcholine receptor channels.

Kalappa BI, Uteshev VV.

Eur J Pharmacol. 2013 Oct 15;718(1-3):226-34. doi: 10.1016/j.ejphar.2013.08.027. Epub 2013 Sep 11.

17.

A type-II positive allosteric modulator of α7 nAChRs reduces brain injury and improves neurological function after focal cerebral ischemia in rats.

Sun F, Jin K, Uteshev VV.

PLoS One. 2013 Aug 9;8(8):e73581. doi: 10.1371/journal.pone.0073581. eCollection 2013.

18.

A positive allosteric modulator of α7 nAChRs augments neuroprotective effects of endogenous nicotinic agonists in cerebral ischaemia.

Kalappa BI, Sun F, Johnson SR, Jin K, Uteshev VV.

Br J Pharmacol. 2013 Aug;169(8):1862-78. doi: 10.1111/bph.12247.

19.

Reduced GABA(A) receptor-mediated tonic inhibition in aged rat auditory thalamus.

Richardson BD, Ling LL, Uteshev VV, Caspary DM.

J Neurosci. 2013 Jan 16;33(3):1218-27a. doi: 10.1523/JNEUROSCI.3277-12.2013.

20.

Responsiveness to nicotine of neurons of the caudal nucleus of the solitary tract correlates with the neuronal projection target.

Feng L, Sametsky EA, Gusev AG, Uteshev VV.

J Neurophysiol. 2012 Oct;108(7):1884-94. doi: 10.1152/jn.00296.2012. Epub 2012 Jul 18.

21.

Somatic integration of single ion channel responses of α7 nicotinic acetylcholine receptors enhanced by PNU-120596.

Uteshev VV.

PLoS One. 2012;7(3):e32951. doi: 10.1371/journal.pone.0032951. Epub 2012 Mar 30.

22.

α7 nicotinic ACh receptors as a ligand-gated source of Ca(2+) ions: the search for a Ca(2+) optimum.

Uteshev VV.

Adv Exp Med Biol. 2012;740:603-38. doi: 10.1007/978-94-007-2888-2_27. Review.

23.

Differences in serotonin receptor expression in the brainstem may explain the differential ability of a serotonin agonist to block seizure-induced sudden death in DBA/2 vs. DBA/1 mice.

Faingold CL, Randall M, Mhaskar Y, Uteshev VV.

Brain Res. 2011 Oct 18;1418:104-10. doi: 10.1016/j.brainres.2011.08.043. Epub 2011 Aug 23.

PMID:
21920504
24.

Mechanisms of facilitation of synaptic glutamate release by nicotinic agonists in the nucleus of the solitary tract.

Kalappa BI, Feng L, Kem WR, Gusev AG, Uteshev VV.

Am J Physiol Cell Physiol. 2011 Aug;301(2):C347-61. doi: 10.1152/ajpcell.00473.2010. Epub 2011 May 25.

25.

Extrasynaptic GABA(A) receptors and tonic inhibition in rat auditory thalamus.

Richardson BD, Ling LL, Uteshev VV, Caspary DM.

PLoS One. 2011 Jan 26;6(1):e16508. doi: 10.1371/journal.pone.0016508.

26.
27.
28.

Abnormal serotonin receptor expression in DBA/2 mice associated with susceptibility to sudden death due to respiratory arrest.

Uteshev VV, Tupal S, Mhaskar Y, Faingold CL.

Epilepsy Res. 2010 Feb;88(2-3):183-8. doi: 10.1016/j.eplepsyres.2009.11.004. Epub 2009 Dec 16.

PMID:
20018491
30.

Heterogeneity of nicotinic acetylcholine receptor expression in the caudal nucleus of the solitary tract.

Smith DV, Uteshev VV.

Neuropharmacology. 2008 Feb;54(2):445-53. Epub 2007 Nov 5.

31.

Histamine decreases myogenic tone in rat cerebral arteries by H2-receptor-mediated KV channel activation, independent of endothelium and cyclic AMP.

Jarajapu YP, Oomen C, Uteshev VV, Knot HJ.

Eur J Pharmacol. 2006 Oct 10;547(1-3):116-24. Epub 2006 Jul 27.

PMID:
16920098
32.

Cholinergic modulation of neurons in the gustatory region of the nucleus of the solitary tract.

Uteshev VV, Smith DV.

Brain Res. 2006 Apr 21;1084(1):38-53. Epub 2006 Mar 20.

PMID:
16546141
33.
34.

Regulation of neuronal function by choline and 4OH-GTS-21 through alpha 7 nicotinic receptors.

Uteshev VV, Meyer EM, Papke RL.

J Neurophysiol. 2003 Apr;89(4):1797-806. Epub 2002 Dec 4.

35.

Activation and inhibition of native neuronal alpha-bungarotoxin-sensitive nicotinic ACh receptors.

Uteshev VV, Meyer EM, Papke RL.

Brain Res. 2002 Sep 6;948(1-2):33-46.

PMID:
12383953
36.
37.

alpha7 receptor-selective agonists and modes of alpha7 receptor activation.

Papke RL, Meyer E, Nutter T, Uteshev VV.

Eur J Pharmacol. 2000 Mar 30;393(1-3):179-95.

PMID:
10771012
39.
40.

Alpha-bungarotoxin-sensitive nicotinic responses in rat tuberomammillary neurons.

Uteshev VV, Stevens DR, Haas HL.

Pflugers Arch. 1996 Aug;432(4):607-13.

PMID:
8764960
41.
42.

Potentiation of glutamate-activated currents in isolated hippocampal neurons.

Zilberter YI, Uteshev VV, Sokolova SN, Motin LG, Eremjan HH.

Neuron. 1990 Nov;5(5):597-602.

PMID:
1977422

Supplemental Content

Loading ...
Support Center